Reasons for participation and non-participation in a randomized controlled trial: Postal questionnaire surveys of women eligible for TOMBOLA (Trial of management of borderline and other low-grade abnormal smears)

Clinical Trials

Volumn 3, Issue 5, 2006, Pages 431-442

  Sharp, Linda ^a   Cotton, C S ^b   Alexander, L ^c   Williams, E ^d   Gray, M N ^b   Reid, M J ^b   Avis, Mark ^e   Cruickshank, Maggie ^e   Duncan, Ian ^e   Hammond, Rob ^e   Jenkins, David ^e   Johnson, Jane ^e   Little, Julian ^e   Murray, Graeme ^e   Neal, Keith ^e   Parkin, David ^e   Robertson, Alistair ^e   Russell, Ian ^e   Seth, Rashmi ^e   Smart, Louise ^e   Walker, Leslie ^e   Waugh, Norman ^e   Whynes, Dave ^e   Chilvers, Claire ^e   Fielding, Katherine ^e   Walker, Eric ^e   more..

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HEALTH SURVEY; HUMAN; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICS; UTERINE CERVIX DYSPLASIA; VAGINA SMEAR;

ADULT; ATTITUDE TO HEALTH; FEMALE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT SELECTION; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UTERINE CERVICAL DYSPLASIA; VAGINAL SMEARS;

EID: 34248538953     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774506070812     Document Type: Article

References (91)

1. SIGN. SIGN50: A guideline developer's handbook. Available from: URL http://www.sign.ac.uk/guideline/fulltext/50/index/html. Accessed 2 May 2006.
2. Prescott RJ, Counsell CE, Gillespie WJ et al. Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess 1999; 3: 20-20.
3. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: A systematic review J Clin Epidemiol 1999; 52: 1143-1156.
4. Mapstone J, Elbourne D, Roberts I. Strategies to improve recruitment to research studies. The cochrane database of methodology reviews 2002; Issue 3. Art No MR00013.pub2. DOI: 10.1002/14651858.MR000013.pub2.
5. McDonald AM, Knight RC, Campbell MK et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials 2006; 7: Available from URL http://www.trialsjournal.com/content/7/1/9. Accessed 2 May 2006.
6. Altman DG. Statistics and ethics in medical research. III How large a sample? Br Med J 1980; 281: 1336-1338.
7. Rothwell PM. External validity of randomised controlled trials: 'to whom do the results of this trial apply?' Lancet 2005; 365: 82-93.
8. Fayter D, McDaid C, Ritchie G, Stirk L, Eastwood A. Systematic review of barriers, modifiers and benefits involved in participation in cancer clinical trials. Centre for Reviews & Disseminations, University of York, 2006.
9. Snowdon C, Elbourne D, Garcia, J and the STEP Study Group. Strategies for trials enrolment and participation study: Case studies. Society for Clinical Trials 26th Annual Meeting. Portland, Oregon, 22-25 May 2005.
10. Francis D, Roberts I, Elbourne D, Campbell, M and the STEPS Study Group. Clinical trials as businesses: Strategies for trials enrolment and participation study. Society for Clinical Trials 26th Annual Meeting. Portland, Oregon, 22-25 May.
11. Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL. Recruitment for controlled clinical trials: Literature summary and annotated bibliography Control Clin Trials 1997; 18: 328-352.
12. Cox K, McGarry J. Why patients don't take part in cancer clinical trials: An overview of the literature Eur J Cancer Care 2003; 12: 114-122.
13. Jenkins V, Fallowfield L. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy Br J Cancer 2000; 82: 1783-1788.
14. Hayman RM, Taylor BJ, Peart NS, Galland BC, Sayers RM. Participation in research: Informed consent, motivation and influence J Paediatr Child Health 2001; 37: 51-54.
15. Madsen SM, Mirza MR, Holm S, Hilsted KL, Kampmann K, Riis P. Attitudes towards clinical research amongst participants and nonparticipants J Intern Med 2002; 251: 156-168.
16. Wiley FM, Ruccione K, Moore IM et al. Parents' perceptions of randomization in pediatric clinical trials. Children Cancer Group Cancer Pract 1999; 7: 248-256.
17. Lara PN Jr, Higdon R, Lim N et al. Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrolment. J Clin Oncol 2001; 19: 1728-1733.
18. Moritz S, Robinson JW, White LJ, Ernst DS, Venner P. Determinants of accrual to prostate cancer clinical trials. Urooncology 2002; 2: 205-211.
19. Kemeny, Peterson BL, Kornblith AB et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003; 21: 2268-2275.
20. Stevens T, Ahmedzai SH. Why do breast cancer patients decline entry into randomised trials and how do they feel about their decision later: A prospective, longitudinal, indepth interview study. Patient Educ Couns 2004; 52: 41-48.
21. McDaid C, Hodges Z, Fayter D, Stirk L, Eastwood A. Systematic review of interventions to increase participation of cancer patients in randomised controlled trials. Centre for Reviews and Dissmeniation, University of York, 2006.
22. Cooley ME, Sarna L, Brown JK et al. Challenges of recruitment and retention in multisite clinical research. Cancer Nurs 2003; 26: 376-384.
23. UK Collaborative Trial of Ovarian Screening. UKCTOCS - UK Collaborative Trial of Ovarian Screening. Available from: URL www.ukctocs.org.uk. Accessed 2 May 2006.
24. Prostate testing for cancer and treatment. ProtecT study - Prostate testing for cancer and Treatment. Available from: URL http://www.epi.bris.ac.uk/protect. Accessed 2 May 2006.
25. Little P, Dorward M, Gralton S et al. A randomised controlled trial of three pragmatic approaches to initiate increased physical activity in sedentary patients with risk factors for cardiovascular disease. Br J Gen Pract 2004; 54: 189-195.
26. de Vreede PL, Samson MM, van Meeteren NL, Duursma SA, Verhaar HJ. Functional-task exercise versus resistance strength exercise to improve daily function in older women: A randomized, controlled trial J Am Geriatr Soc 2005; 53: 2-10.
27. Hininger I, Favier M, Arnaud J et al. Effects of a combined micronutrient supplementation on maternal biological status and newborn anthropometrics measurements: A randomized double-blind, placebocontrolled trial in apparently healthy pregnant women. Eur J Clin Nutr 2004; 58: 52-59.
28. Emmons KM, Hammond SK, Fava JL, Velcier WF, Evans JL, Monroe AD. randomized trial to reduce passive smoke exposure in low-income households with young children Pediatrics 2001; 108: 18-24.
29. McCarthy CR. Historical background of clinical trials involving women and minorities Academic Medicine 1994; 69: 695-698.
30. Merkatz. RB. Inclusion of women in clinical trials: A historical overview of scientific, ethical, and legal issues J Obstet Gynecol Neonatal Nurs 1998; 27: 78-84.
31. Killien M, Bigby JA, Champion V et al. Involving minority and underrepresented women in clinical trials: The National Centers of Excellence in Women's Health. J Womens Health Gend Med 2000; 9: 1061-1070.
32. Prout MN, Fish SS. Participation of women in clinical trials of drug therapies: A context for the controversies. Medscape Womens Health 2001; 6: 1-1.
33. Anonymous. Recruitment of women to clinical trials. Lancet 2001; 358: 853-853.
34. Benson JR. Recruitment of women into trials. Lancet 2002; 359: 164-164.
35. Thornton H, Dixon-Woods M. Recruitment of women into trials. Lancet 2002; 359: 164-164.
36. Bartlett EE. Recruitment of women into trials. Lancet 2002; 359: 165-165.
37. Smyth A, Hyman-Taylor P, Lewis S, Knox A, Stephenson T. Recruitment of women into trials Lancet 2002; 359: 165-166.
38. Gorkin L, Schron EB, Handshaw K et al. Clinical trial enrollers vs. nonenrollers: The Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project Control Clin Trials 1996; 17: 46-59.
39. Stone VE, Mauch MY, Steger K, Janas SF, Craven DE. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort J Gen Intern Med 1997; 12: 150-157.
40. Du W, Gadgeel SM, Simon MS. Predictors of enrollment in lung cancer clinical trials Cancer 2006; 106: 420-425.
41. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities JAMA 2004; 291: 2720-2726.
42. Tangrea JA, Adrianza ME, Helsel WE. Patients' perceptions on participation in a cancer chemoprevention trial Cancer Epidemiol Biomark Prev 1992; 1: 325-330.
43. Peterson ED, Lytle BL, Biswas MS, Coombs L. Willingness to participate in cardiac trials. Am J Geriatr Cardiol 2004; 13: 11-15.
44. Creel AH, Losina E, Mandl LA et al. An assessment of willingness to participate in a randomized trial of arthroscopic knee surgery in patients with osteoarthritis. Contemp Clin Trials 2005; 26: 169-178.
45. Advisory Committee on Human Radiation Experiments. Advisory Committee on Human Radiation Experiments - final report: Chapter 16 - subject interview study. Available from: URL http://www.eh.doe.gov/ohre/roadmap/ achre/chap16.html. Accessed 2 May 2006.
46. Neill KM, Chessa F. Recruitment and retention of women in nontherapeutic clinical trials Appl Nurs Res 1998; 11: 148-151.
47. The TOMBOLA Group. Trial of Management of Borderline and Other Low grade Abnormal smears (TOMBOLA): Trial design. Contemp Clin Trials (in press). Available online 28 April 2006 from URL: http://www.sciencedirect.com/ science?_ob=Mimg&_imagekey= B7P72-4JTXCVS-1-3&_cdi= 24646&_user=152381&∨ig= browse&_coverDate= 04%2F28%2F2006&_sk=999999999&view= c&wchp= dGLbVzz-zSkzV&md5=0b4c1cd226c9dea17b217314445750ff&ie=/ sdarticle.pdf.
48. Carstairs V, Morris R. Deprivation and health in Scotland Health Bull 1990; 48: 162-175.
49. Stanford PD, Monte DA, Briggs FM et al. Recruitment and retention of adolescent participants in HIV research: Findings from the REACH (Reaching for Excellence in Adolescent Care and Health) Project. J Adolesc Health 2003; 32: 192-203.
50. Verheggen FW, Nieman F, Jonkers R. Determinants of patient participation in clinical studies requiring informed consent: Why patients enter a clinical trial Patient Educ Couns 1998; 35: 111-125.
51. Fry C, Dwyer R. For love or money? An exploratory study of why injecting drug users participate in research Addiction 2001; 96: 1319-1325.
52. Naslund GK, Fredrikson M, Hellenius M, De Faire U. Determinants of compliance in men enrolled in a diet and exercise intervention trial: A randomized, controlled study. Patient Educ Couns 1996; 29: 247-256.
53. Ahluwalia JS, Richter K, Mayo MS et al. African American smokers interested and eligible for a smoking cessation clinical trial: predictors of not returning for randomization. Ann Epidemiol 2002; 12: 206-212.
54. Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD. Response rates among control subjects in casecontrol studies Ann Epidemiol 1995; 5: 245-249.
55. Cunny KA, Miller HW. Participation in clinical drug studies: Motivations and barriers. Clin Ther 1994; 16: 273-282.
56. Koblin BA, Avrett S, Taylor PE, Stevens CE. Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 165-171.
57. Tolmie EP, Mungall MM, Louden G, Lindsay GM, Gaw A. Understanding why older people participate in clinical trials: The experience of the Scottish PROSPER participants Age Ageing 2004; 33: 374-378.
58. Rosenbaum JR, Wells CK, Viscoli CM, Brass LM, Kernan WN, Horwitz RI. Altruism as a reason for participation in clinical trials was independently associated with adherence. J Clin Epidemiol 2005; 58: 1109-1114.
59. Shuhatovich OM, Sharman MP, Mirabal YN, Earle NR, Follen M, Basen-Engquist K. Participant recruitment and motivation for participation in optical technology for cervical cancer screening research trials. Gynecol Oncol 2005; 99: S226-S231.
60. Pickersgil A, Furniss H, Seif MW. Why do women volunteer to participate in clinical studies? J Obstet Gynaecol 1998; 18: 68-71.
61. Lynoe N, Sandlund M, Dahlqvist G, Jacobssen L. Informed consent: Study of quality of information given to participants in a clinical trial. Br Med J 1991; 303: 610-613.
62. Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Update of Cochrane database of systematic reviews 2004, Issue 2. Art No CD003974. DOI: 10.1002/14651858.CD003974.pub2.
63. Hietanen P, Aro AR, Holli K, Abetz P. Information and communication in the context of a clinical trial Eur J Cancer 2000; 36: 2096-2104.
64. Robinson EJ, Kerr C, Stevens A, Lilford R, Braunholtz D, Edwards S. Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials Soc Sci Med 2004; 58: 811-824.
65. Wright JR, Whelan TJ, Schiff S et al. Why cancer patients enter randomized clinical trials: Exploring the factors that influence their decision. J Clin Oncol 2004; 22: 4312-4318.
66. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: Informed consent in psychiatric research Int J Law Psychiatry 1982; 5: 319-329.
67. Appelbaum PS. Clarifying the ethics of clinical research: A path toward avoiding the therapeutic misconception Am J Bioeth 2002; 2: 22-23.
68. Lidz CW, Appelbaum PS, Grisso T, Renaud M. Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med 2004; 58: 1689-1697.
69. Greenaway D, Haynes M. Funding universities to meet national and international challenges. Available from: URL www.nottingham.ac.uk/ economics/funding/funding.pdf. Accessed 2 May 2006.
70. Learning and Skills Council (Department for Education & Skills). Student numbers at colleges in the further education sector and external institutions in England in 2001/02. Available from: URL www.dfes.gov.uk/ rsgateway. Accessed 28 March 2005.
71. Bachmann MO, Eachus J, Hopper CD et al. Socioeconomic inequalities in diabetes complications, control, attitudes and health service use: A crosssectional study. Diabetic Med 2003; 20: 921-929.
72. de Walle HE, de Jong-van den Berg, LT. Insufficient folic acid intake in the Netherlands: What about the future? Teratology 2002; 66: 40-43.
73. Lowry DA. Issues of non-compliance in mental health. J Adv Nurs 1998; 28: 280-287.
74. Hussain-Gambles M, Leese B, Atkin K, Brown J, Mason S, Tovey P. Involving South Asian patients in clinical trials. Health Technol Assess 2004; 8.
75. Kucia AM, Horowitz JD. Is informed consent to clinical trials and "upside selective" process in acute coronary syndromes? Am Heart J 2000; 140: 94-97.
76. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: A systematic review JAMA 2004; 292: 1593-1601.
77. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet 2001; 358: 1772-1777.
78. Gath DH, Hallam N, Mynors-Wallis L, Day A, Bond SAK. Emotional reactions in women attending a UK colposcopy clinic J Epidemiol Community Health 1995; 49: 79-83.
79. Bell S, Porter M, Kitchener H, Fraser C, Fisher P, Mann E. Psychological response to cervical screening Prev Med 1995; 24: 610-616.
80. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: Cross sectional questionnaire study Br Med J 2004; 328: 1293-1300.
81. Gray NM, Sharp L, Cotton SC et al. Psychological effects of a low-grade abnormal cervical smear test result: Anxiety and associated factors. Br J Cancer 2006; 94: 1253-1262.
82. Onyeka BA, Martin-Hirsch P. Information leaflets, verbal information and women's knowledge of abnormal cervical smears and colposcopy J Obstet Gynaecol 2003; 23: 174-176.
83. Ling J, Rees E, Hardy J. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer 2000; 36: 621-626.
84. Brewster WR, Anton-Culver H, Ziogas A et al. Recruitment strategies for cervical cancer prevention study. Gynecol Oncol 2002; 85: 250-254.
85. Richardson MA, Post-White J, Singletary SE, Justice B. Recruitment for complementary/alternative medicine trials: Who participates after breast cancer. Ann Behav Med 1998; 20: 190-198.
86. Ward E, King M, Lloyd M, Bower P, Friedli K. Conducting randomized trials in general practice: Methodological and practical issues. Br J Gen Pract 1999; 49: 919-922.
87. van der Windt DA, Koes BW, van Aarst M, Heemskerk MA, Bouter LM. Practical aspects of conducting a pragmatic randomised trial in primary care: Patient recruitment and outcome assessment Br J Gen Pract 2000; 50: 371-374.
88. Bell-Syer SE, Moffett JA. Recruiting patients to randomized trials in primary care: Principles and case study Fam Pract 2000; 17: 187-191.
89. Huibers MJ, Bleijenberg G, Beurskens AJ et al. An alternative trial design to overcome validity and recruitment problems in primary care research. Fam Pract 2004; 21: 213-218.
90. Silverman WA, Altman DG. Patients' preferences and randomised trials Lancet 1996; 347: 171-174.
91. Torgerson D, Sibbald B. Understanding controlled trials: What is a patient preference trial? Br Med J 1998; 316: 360-360.